In this EASL Molecular Tumour Board (EASL MTB) the multidisciplinary panel of experts will discuss a clinical case of HCC-neuroendocrine transition. Watch now to listen to the discussion and get more insight into precision oncology based on molecular data in primary liver malignancies.
©2019 - EASL. All Rights Reserved. Powered by Enovation.